Introduction
We have been making macroscopic tools to enhance our lives for at least 3million years,beginning with hammerstones and hand axes.
[1] Formost of this history,wemade our tools by hand. Over the past two millennia there was sporadic progress in the use of machines to advance the process of toolmaking, which progressively yielded key elements of industrialization.
[2] Then in the eighteenth and nineteenth centuries the power of automated manufacturing hit full stride,h uman innovation reached an inflection point, and the Industrial Revolution transpired. This marked aturning point in history that transformed societies and ultimately improved the quality and span of human life in many parts of the world. [3] Around the same time,t he first organic molecules were synthesized by hand, opening the possibility of rational toolmaking on the molecular scale. [4] Over the past nearly 200 years,there has been tremendous progress on this front, [5] and small molecules have made many important impacts. Such compounds serve as most of our best medicines, biological probes,c rop protectants,f ood preservatives,a s well as key components in organic materials,d yes,p aints, perfumes,f lavorants,a nd lotions.G iven all this impact already,i ti se xciting to consider that most of the functional potential that small molecules possess likely remains untapped. [6] This is because this class of chemical matter can also perform many frontier functions that have been minimally utilized to date.T hese include modulating protein-protein interactions, [7] allosterically modifying protein function, [8] acting as prostheses on the molecular scale, [9] serving as next-generation biological probes, [10] enabling miniaturized diagnostics, [11] harvesting sunlight, [12] transducing energy, [13] emitting light, [14] initiating self-healing, [15] acting as molecular magnets, [16] acting as redox flow batteries, [17] enabling next generation computing, [18] and superconducting. [19] Harnessing this untapped functional potential on the molecular scale could help address some of the most important problems facing societies today.H owever,t he hand-crafted and thus inherently slow and specialist-dependent process through which most small molecules are still synthesized represents as ignificant bottleneck in such efforts.T he automation of small-molecule synthesis has the potential to eliminate this bottleneck and thereby enable widespread innovation on the molecular scale.
Thep otential benefits of automating small-molecule synthesis were contemplated by even some of the earliest pioneers.F igure 1s hows aw onderful photograph of Albert Eschenmoser and R. B. Woodward observing what was dubbed a" B12-and B13-making machine" at ETH around 1979. [20] Substantial progress has since been made towards the automated synthesis of many small-molecule targets. [21] These advances fall into two general categories.T he first category includes highly optimized machines for the customized synthesis of one specific small molecule.T his category is comparable to an optimized industrial process that exclusively manufactures one macroscopic product. This approach is now widely pursued in industry to maximize efficient access to specific small molecules in sufficient quantities and with reproducible quality and involves aw ide range of both batch and/or flow-based processes.
Todayweare poised for at ransition from the highly customized crafting of specific molecular targets by hand to the increasingly general and automated assembly of different types of molecules with the push of abutton. Creating machines that are capable of making many different types of small molecules on demand, akin to that which has been achieved on the macroscale with 3D printers,ischallenging. Yeti mportant progress is being made towardt his objective with two complementary approaches:1)Automation of customized synthesis routes to different targets by machines that enable the use of many reactions and starting materials,and 2) automation of generalized platforms that make many different targets using common coupling chemistry and building blocks.Continued progress in these directions has the potential to shift the bottleneck in molecular innovation from synthesis to imagination, and thereby help drive an ew industrial revolution on the molecular scale. Thes econd category alternatively aims to accelerate discovery of new small-molecule function and/or make small amounts of known-to-be-useful small molecules,ondemand. This requires general machines that can synthesize many different types of small molecules.T his goal is akin to achieving on the molecular scale what 3D printers have enabled on the macroscopic scale. [22] This has proven to be amuch more challenging goal. However, important progress is being made with two complementary approaches.T he first aims to automatically execute customized synthesis routes to each target by constructing af lexible synthesis machine capable of performing many different types of reactions and employing many different starting materials.T his approach has the advantage of leveraging al arge body of precedent because it mirrors the highly customized approach that organic chemists have primarily used for the past two centuries to make small molecules by hand. Thes econd approach alternatively aims to make most small molecules using common coupling chemistry and building blocks,similar in concept to creating many different structures from the same bucket of Lego bricks.While this approach requires new ways of thinking about small-molecule synthesis and the development of advanced strategies and methods,i th as the major advantage of potentially enabling broad access to small-molecule chemical space with one simple machine and one shelf of building blocks.Continued progress in all of these exciting directions will unleash the extraordinary untapped functional potential that small molecules possess,t hereby driving anew industrial revolution on the molecular scale.
One Machine-One Small Molecule
Thec apacity for automation to improve the scalability, safety,efficiency,and reproducibility of manufacturing aspecific macroscopic tool are clear and even quantifiable.T he first industrial spinning machine,called the "spinning jenny", could produce 4-8 times the amount of yarn ahuman spinner could produce by hand in the same timeframe. [23] The Fourdrinier machine enabled the continuous manufacturing of paper with consistently high quality and was also faster than the traditional manual production of mold-made paper. [24] Thea utomation of glass bottle production made the process safer, because the hot glass is completely handled and shaped by machines. [25] Tr ansferring the concept of automation to specific chemical processes can lead to similar improvements in scalability,safety,efficiency,and reproducibility.S uch automation has been pursued and successfully applied for decades,a nd advancing the capacity for such automation remains the focus of many current research groups. [26] Further progress in this field will continue to have am ajor impact on society by improving access to specific molecules known to have auseful function.
Scalability
At least partial automation of customized syntheses of useful molecules has become common in industry,and alarge driver of this is the positive impact automation can have on scalability. [27] Chemists and engineers at Eli Lilly recently demonstrated an end-to-end fully automated synthesis of 24 kg of prexasertib monolactate monohydrate (7)f or use in human clinical trials (Scheme 1). This process involved ac ombination of batch and multistep continuous flow techniques under current good manufacturing practice (cGMP) conditions,a nd the entire apparatus fit inside as tandard-sized fume hood. This synthesis also exemplified many additional advantages of automated manufacturing: Thep roduct was produced in overall high yields (75-85 %), high purity (99.72-99.82 %HPLC-area), and greater efficiency in comparison to am anual batch process.M oreover, performing the first step,apyrazole formation, in an automated flow-based format, keeps the overall hydrazine present at any time low,e liminating an important safety hazard. Safety was further increased by eliminating the need for human handling of the potent biologically active intermediates and final product. [28] Another example showing the advantages of automation for scale-up was reported by the Cork group.T hey were able to automatically produce on kilogram scale akey boronic acid intermediate (8) f or the manufacturing of TAK-117, as elective PI3Ka inhibitor currently in Phase 1b clinical trials (Scheme 2). In the original batch process,t he boronic acid moiety was introduced through an expensive Pd-catalyzed borylation. [29] Additionally,t he bis-boronic acid starting material was shown to be prone to oxygen-mediated degradation and as ource of potentially genotoxic impurities. [30] Melanie Trobe was born in 1988 in Austria. She studied chemistry at the Graz University of Technology and University of Graz (Austria Thus,u nlike the Pd-catalyzed reaction, synthesizing the key boronic acid intermediate through al ithiation-borylation procedure had many potential advantages,i ncluding increased efficiencya nd safety;h owever manually performing the corresponding lithiation chemistry on scale was associated with important challenges.A utomation of this process using batch conditions proved to be difficult because of clogging issues.H owever,t his reaction sequence was successfully automated under continuous flow conditions in conjunction with abatch workup and isolation of the desired intermediate on kilogram scale.Even though the raw material costs of the continuous flow method exceed the costs of the Pd-catalyzed batch version because of the necessary Boc-protection, the flow process has potential benefits arising from avoiding the use of Pd and potentially mutagenic boron reagents.B ys witching to af low process this reaction was also made safer and more efficient owing to as hort residence time in the flow reactor and the use of less toxic chemicals.
[31]
Safety
Safety can also be ap rimary advantage of automating as pecific chemical process.F or example,s afety is an important concern when working with radioactive materials,a nd automation of customized batch synthesizers on the laboratory scale can offer as afer way to synthesize radiolabeled substances.P ET imaging in particular has become an important diagnostic tool in oncology, but in addition to safety,ashort 18 Fh alflife makes the synthesis and distribution of these compounds challenging. Automation can address these problems by Scheme 2. Flow production of the boronic acid key intermediate (8) for the manufacturing process of TAK-117.
Scheme 3. Example for abatch processes for the synthesis of the radiolabeled drug molecule [ allowing the dose-on-demand preparation of these small molecules on site. [32] [33] Further examples for the automated synthesis of radiolabeled compounds include Pittsburg compound-B ( 11 C-labeled derivative), [34] paclitaxel ( 18 F-labaled derivative) [35] ,a nd other 18 F-as well as 68 Ga-labeled compounds. [36] In addition to the safety hazards associated with certain chemical substances,e xtreme conditions and exothermic reactions can also be especially dangerous on large scale, and these risks can be mitigated by automation. Forexample, Jamison and Snead recently reported athree-step process for automatically manufacturing ibuprofen (10) , which includes the automation of ak ey step that involves an exothermic reaction and quench (Scheme 4). Specifically,the first step is aFriedel-Crafts acylationperformed neat at 90 8 8Cwith AlCl 3 as Lewis acid and quenched with HCl, resulting in neat product separating from an aqueous solution containing aluminum byproducts.T he risks normally associated with running this type of exothermic reaction and quench in batch mode were circumvented by using automated flow chemistry, since only asmall amount of material is utilized at any given time.The same advantages were observed for the second step in which neat, melted ICl induced an oxidative 1,2-aryl rearrangement to form the targeted methyl ester,w hich was then saponified in the last chemical transformation of this sequence.U tilizing this process,u pt o7 0kgo fi buprofen (5) could be safely synthesized per year with equipment that fits in as tandard laboratory fume hood. [37] 2.3 Speed Automated synthesis platforms can also increase the speed of achemical process,aswas recently demonstrated by Jamison and co-workers with an automated flow-based platform. Specifically,t he total synthesis of ciprofloxacin hydrochloride (11)w as achieved in nine minutes under continuous flow conditions through al inear reaction sequence of six chemical reactions in five flow reactors, followed by offline acidification and filtration (Scheme 5).
Thef inal product was isolated in 60 %y ield after the two additional offline steps,m aking this an overall very timeefficient process. [38] As described above,flow reactors can also enable safer handling of sensitive chemicals and dangerous reactions as well as fast and accurate temperature control, often leading to cleaner formation of even highly complex products. [39] Flow synthesizers can also have limitations,such as clogging or insufficient mixing of suspensions. [40] [41] [42] [43] 
Reproducibility
Another important advantage of automated synthesis can be improved reproducibility because automation can eliminate sources of human error and enable strict end-to-end process control. In 2013, the Tr out group presented an example of an end-to-end, integrated continuous manufacturing plant for the pharmaceutical aliskiren hemifumarate (12) (Scheme 6). [44] Theprocess includes all reactions,separations, crystallizations,d rying, and formulation procedures,a nd results in 12 formulated as atablet. Theentire sequence runs continuously and can produce 2.7 million tablets per year with each tablet containing precisely 112 mg of the free base form of aliskiren. [45] In another example,t he Ley group reported ah ighly reproducible and robust route for the synthesis of 5-methyl-4-propylthiophene-2-carboxylic acid (13) , an important precursor for the anticancer drug candidate AZ82 (Scheme 7). This work demonstrated that ac ombination of flow and batch conditions can be exceptionally effective for optimizing time and yield. [40] Other groups have also recently emphasized the advantages of combining batch and continuous flow synthesizers. [41] [42] [43] Leveraging all of these advantages,i ti sn ow increasingly commonplace for pharmaceuticals and other specific small molecules known to have useful functions to be manufactured using at least partially automated customized synthesis routes. In contrast, the use of automated synthesis in the process of discovering new small molecule function is much less common. Harnessing the power of automation in this context will require more general synthesizers that have the capacity to automatically prepare many different types of small molecule targets.T his is an exceptionally challenging but also potentially transformative objective.
One Machine-Many Small Molecules
One of the most important benefits of automated manufacturing is the power to enable innovation by accelerating and expanding access to the process of prototype creation. On the macroscopic scale,generalized machines that can make many different types of tools have been am ajor driver of such innovation. Theu ltimate example is the 3D printer, which enables production of an extraordinary breadth of different macroscopic objects by non-specialists,r anging from prosthetic limbs,t or eplacement parts for specialized instrumentation, to fully-functioning cameras,a ll at the push of abutton. [46] General synthesizers for similarly enabling on-demand access to certain classes of organic molecules,n amely peptides, [47, 48] oligonucleotides, [49] and increasingly oligosaccharides [50, 64] have been successfully developed, and the impact on science,m edicine,a nd technology has been transformative.T oh ighlight just af ew examples,a utomatically synthesized proteins, [51] genes, [52] and even complete genomes [53] pushed the development of the field of synthetic biology.New classes of therapeutics emerged owing to easier access and optimization of peptide-and oligonucleotidebased drug candidates, [54] and substantial recent progress in automated oligosaccharide synthesis has led to important impacts in vaccine development. [55] Thea chievement of generalized synthesis platforms for making many different types of small molecules has proven to be substantially more challenging.However,exciting progress is being made by using two complementary approaches: 1) Automation of customized synthesis routes to each target by flexible machines that enable the use of many different reactions and starting materials,a nd 2) automation of generalized synthesis platforms that make many different small molecule targets using common coupling chemistry and building blocks.
Automation of Customized Synthesis Routes
Organic chemists typically design and develop customized routes to synthesize each small molecule target through as ystematic planning algorithm known as retrosynthetic analysis. [56] [57] [58] [59] In this inherently customized approach, one theoretically considers use of all chemical reactions in the reverse synthetic direction to systematically deconstruct as pecific target into as et of starting materials.O nce ab est customized path for deconstructing that specific target has been identified, forward execution of the corresponding customized synthesis route is manually attempted in the lab. If the goal is to make as efficiently as possible one specific molecule,oracollection of structurally very similar molecules known to have an important function, this customized approach has substantial advantages because it allows each synthetic solution to be highly optimized for each specific problem.
There are also,h owever,i mportant disadvantages of this customized approach, especially when it comes to the goal of generalized automation. Specifically,i tu sually requires the de novo design of an ew synthetic route for each target, the development and/or optimization of many different types of reactions,access to aunique set of starting materials,arange of different equipment, and distinct safety arrangements. Collectively,t hese features tend to make the design and execution of customized synthetic routes slow and specialistdependent. Synthesis thus remains an important bottleneck when the goal is to discover,u nderstand, and optimize new molecular function.
One approach for generally automating small-molecule synthesis aims to build highly versatile machines that are capable of automatically replicating this classic customized approach for designing and executing synthesis pathways.
In theory,the design process could be automated through the use of computerized retrosynthetic analysis.T his is ac hallenging problem, but important progress has recently been made in this direction. [56] [57] [58] [60] [61] [62] As such algorithms and broad access to the required computing power continue to advance and as new opportunities opened up by recent advances in artificial intelligence/machine-learning are leveraged, it is likely that asubstantial portion of such customized synthetic planning can be achieved automatically. [60, 62, 63] Ap otentially even more challenging problem associated with this approach is that it requires creating am achine that can perform as many different types of reactions as possible,is compatible with many different types of starting materials and reagents,a nd can execute many different types of purifications.E ach of these goals alone is challenging;i n combination, they represent af ormidable task.
Nonetheless,i mportant progress has been made in the development of automated platforms that aim to replicate the customized approach for small molecule synthesis.A sd escribed below,h andling air sensitive reactions,o n-demand synthesis of multiple different pharmaceuticals,a nd high throughput synthesis of various targets have all been achieved with this approach.
In an early example,B olla introduced an automatic apparatus capable of performing an umber of different chemical reactions on the laboratory scale in 1985 (Figure 2A) . Thep rinciple application of this machine was the optimization of reaction parameters when transferring from laboratory scale to pilot plant. Ac omputer interface and customized programming language was developed that enabled chemists to readily utilize the system. [65] Figure 2. Examples of early automatedsynthesis systems.
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Additional early prototypes were developed by Okamota and Deuchi ( Figure 2B,C) . [66] These flexible robotic workstations were similarly designed and utilized to enable the transition from laboratory scale to pilot plant and even fullscale manufacturing. It was also demonstrated that these automated synthesis systems can perform av ariety of common organic reactions on the gram-scale and enable material throughput by running 24 haday. [66] In 2000, the Otera group developed MEDLEY,a n automated one-pot synthesizer capable of conducting av ariety of air sensitive chemical reactions (Scheme 8). The completely sealed apparatus can perform reactions under inert atmosphere from À78 8 8Ct or oom temperature.M ED-LEY can also perform as equence of multiple chemical transformations within one reaction vessel. [67] Ther eservoirs of the synthesizer can be charged with different reagents,and Scheme 8. Syntheses performed with MEDLEY and aschematic of MEDLEY.A RS = automatic reaction system, OTf = triflate. Reprinted (adapted) with permission from Ref. [67] .C opyright2 000, American Chemical Society.
addition, reaction time,and temperature can be controlled by the automated reaction system. This automated reaction system also initiates the quenching process after the reaction sequence is finished. Work-up,p urification, and analysis of the product must still be done by hand. [67] TheO tera group utilized MEDLEY to carry out av ariety of chemical transformations including air-sensitive organolithium and Grignard chemistry as well as transition-metal-catalyzed cross-coupling reactions. [68] They also synthesized 3-substituted 5-(beta-sulfonyl vinyl)indoles by in situ generation of toxic vinyl sulfone. [69] Another batch-based automated synthesizer for air sensitive reactions,c alled ChemKonzert (Scheme 9), was introduced by the Takahashi group in 2010. In addition to having similar features as MEDLEY,C hemKonzert contains an additional centrifugal separator to efficiently achieve liquidliquid extraction in which the phases are separated by using the different electric conductivities of the two layers.I thas also been demonstrated that ChemKonzert can perform twostep reactions between 0 8 8Ca nd reflux temperature and is able to handle air and moisture sensitive reagents.T he instrument can perform many of the typical solution-phase Scheme 9. Synthesis performed with ChemKonzert and aschematic of ChemKonzert including two reaction vessels (RF1 and RF2), acentrifugal separator (SF, 700 mL), two receivers (SF1 and SF2, 500 mL), two glass filters (FF1 and FF2, 500 and 100 mL), 12 substrate and reagent reservoirs( RR1-RR12). BOM = benzyloxymethyl, Cbz = carboxybenzyl, EE = ethoxyethyl, Fmoc = fluorenylmethoxycarbonyl, PG = protecting group, TBS = tert-butyldimethylsilyl, THP = tetrahydropyranyl, Trt = trityl. Reprinted (adapted) with permission from Ref. [70] .C opyright 2009 American Chemical Society.
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Chemie reactions used in the pharmaceutical and chemical industries that do not require the use of high pressure or extensive cooling. In contrast to MEDLEY,the workup is also included in the automated process.Avariety of different reactions were performed on ChemKonzert, including the introduction of protecting groups to alcohols as well as amines,aMasamune reaction to get access to b-keto esters,anO-alkylation reaction, Weinreb amidation followed by Grignard addition to synthesize ketones, [70] af ormal total synthesis of Taxol (14) [71] ,a nd at otal synthesis of Spiruchostatin B( 15). [72] Recently,t he Takahashi group also demonstrated the automated synthesis of a-amino aldehydes in athree-step process exclusively performed by ChemKonzert. [73] In addition to these automated batch synthesizers,avariety of flow-chemistry-based generalized automated platforms have been pursued as well. Three groups from MIT developed ar econfigurable flow-reactor for on-demand synthesis of various pharmaceuticals (Scheme 10). Thes ystem is assembled by modules with special functions (reactors and separators), which can be used or skipped in the synthesis process as needed. Continuous drug manufacturing on ar econfigurable flow system could be particularly useful for pharmaceuticals with as hort shelf life and/or to provide cheaper access to pharmaceuticals for small patient populations.T od emonstrate the flexibility of this on-demand flow reactor, four different pharmaceuticals,d iphenhydramine hydrochloride (16) , lidocaine hydrochloride (17), diazepam (18) , and fluoxetine hydrochloride (19) , were produced using this reconfigurable system. [74] Additional efforts have been directed toward the development of high-throughput micro flow reactors,w hich can be used for rapid method optimization by integrating the flow reactor into ac hip,f ollowed by automated HPLC/LC-MS analysis. [75] Over the past decade,E li Lilly has developed an automated synthesis lab designed to enable high-throughput drug discovery (Scheme 11). [76] This remote-controlled auto- Taking an alternative direction to creating af lexible synthesizer,t he Cronin group has combined ar obotic platform with a3Dprinter to print optimized reaction vessels for different reactions and scales.S uch as ystem automatically synthesized ibuprofen (10)o nt hree different reaction scales controlling the parameters of the synthesis with custom software.I na ddition, catalyst-silicone materials were incorporated into the 3D-printed device,allowing aversatile use of the reaction vessels based on the specific needs for the particular experiment. [77] Recent advances demonstrate progress toward digitization of as ynthesis process with 3D-printable series of vessels for reactions and purifications. [78] Targeted developments in this field include further enabling robotic platforms to handle complete synthetic routes, including work-up and purification steps. [79] 
Automation of Generalized Synthesis Processes
Given some of the inherent limitations of the customized approach for small-molecule synthesis,p articularly when it comes to automation, it is exciting to consider whether alternative and more generalized strategies can be developed. Inspiration for such an approach can be found in the history of building-block-based construction on the macroscopic scale. In the mid-eighteenth century Samuel Bentham pioneered the concept of interchangeable parts in the form of pulley blocks for sailboats.A utomated manufacturing was recognized as critical for the success of this approach, as it maximized the standardization of size and quality of these parts as well as scalability and capacity for on-demand production. [80] Half ac entury later,H onore LeBlanc and Eli Whitney pioneered the idea of interchangeable parts in the manufacturing of muskets. [81, 82] Soon thereafter,H enry Ford added the concept of the assembly line to similarly accelerate the iterative modular manufacturing of automobiles. [81] Scheme 11. Synthesis performed with the automatedsynthesis lab developed by Eli Lilly and schematic with 1) input/outputd evice, 2) bench for heated reactions,3) bench with special functions as cooling, microwave and flow,4)work-up bench, and 5) analytics.
Not only does this type of building-block-based construction enable the efficient, reproducible,a nd automated assembly of as pecific object but such platforms are also inherently flexible.T hat is,t hey can make an extraordinary range of different targets through common assembly processes and the simple mixing and matching of common building blocks.T his enables the on-demand production of new prototypes,e ven by non-specialists,w hich powerfully and broadly enables innovation. Asimple example of this can be seen in the large number of different structures ac hild can build with ab ucket of Lego bricks.B uilding-block-based approaches have similarly enabled consumer-driven personalized design and construction of new homes,d esktop computers,c ars,e tc.,a nd new manufacturing execution systems have been developed to facilitate such on-demand customized production. [83] Thea bility to produce many different products with the same manufacturing process set the stage for the rapid discovery of new tools and machines, which was ahallmark of the Industrial Revolution.
Encouragingly,asimilar type of building-block-based assembly has been realized on the molecular scale for certain subsets of targets,a sb est demonstrated with automated synthesis of peptides, [47] oligonucleotides, [49] and, increasingly, oligosaccharides. [50] Given all the major advantages and remarkable impact that these platforms have made already, it is exciting to ask whether many,o re ven most, small molecules might be accessed through an analogous buildingblock-based approach.
Increasing evidence suggests that this goal is achievable. First, despite their substantial diversity,m any types of small molecules are inherently modular.T his includes natural products,m ost of which are biosynthesized through five major pathways,e ach of which employs as mall number of common reactions and only ah andful of building blocks (Figure 3) . Consistent with this inherent modularity,arecent study revealed that more than 75 %o fa ll polyene natural product motifs can be prepared through the iterative assembly of just 12 building blocks. [84] An ongoing similar analysis of most natural products suggests that such modularity may be more pervasive. [85] Moreover,arecent analysis of all 1086 approved small-molecule drugs also found ah igh degree of redundancya tt he fragment level. Most common were heterocyclic motifs including piperidine (72 drugs), pyridine (62 drugs), piperazine (59 drugs), cephem (41 drugs), pyrrolidine (37 drugs), thiazole (30 drugs), and 16 additional heterocycles found in over 10 drugs. [86] Many different materials are highly modular as well, often being constructed from iterative units of heterocycles,a ryl rings,and/or double bonds.T his collective inherent modularity suggests that aw ide range of different functions can be achieved from common subunits and that many different types of small molecules and corresponding functions should be accessible from common sets of building blocks.
It is also encouraging that many different types of iterative synthesis methods have been developed that enable the modular construction of certain types of small molecules. [87] These include early pioneering examples such as Yoshida, Isoe,a nd co-workers iterative route to optically active polyols through the iterative addition of alpha-alkoxysilane building blocks, [88] Evans and co-workers iterative applica- 
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Chemie tion of diastereoselective aldol reactions to generate polyketide motifs, [89] and Moore and co-workers development of iterative Sonagashira couplings to generate poly-arylalkynes. [90] Most of these platforms target the synthesis of specific classes of small-molecule structures,b ut increasing evidence suggests that iterative platforms can also be developed that are both general and automated.
Forexample,aniterative synthesis platform based on the assembly of N-methyliminodiacetic acid (MIDA)-boronate building blocks has been used to prepare arapidly growing list of structurally distinct small molecules by many different groups worldwide (Figure 4) . [84, [91] [92] [93] [94] This platform leverages the capacity of the trivalent MIDA-ligand to reversibly block the reactivity of aboronic acid through the rehybridization of The MIDAligand can also be removed under aqueous or mild basic conditions,w hich reveals the free boronic acid. [95] This permits the iterative assembly of bifunctional halo MIDA-boronate building blocks through recursive cycles of boronic-acid-selective coupling followed by boron deprotection. [94, 96, 97] This method is also suitable for coupling highly unstable boronic acids because reactive boronic acid species can be slowly released during the reaction from the typically stable,c rystalline MIDA-boronate form. [98] [99] [100] [101] To implement this modular approach, practical access to the corresponding MIDA-boronate building blocks is required. Encouragingly,h undreds of MIDA-boronates are already commercially available and widely utilized. [102] [103] [104] [105] [106] Moreover,r ecent reports from many different research groups demonstrate that awide range of otherwise challenging-to-access MIDA-boronate building blocks can be prepared from MIDA-boronate starting materials. [91, 93, 96, [99] [100] [101] [102] [103] [104] [105] [106] [107] Leveraging the advances described below,there is also ample opportunity to automate the process of building-block synthesis,w hich has the potential to substantially increase the efficiency with which new building blocks can be sustainably accessed on demand.
It was also recently reported that this increasingly general platform for building-block-based small-molecule synthesis can be automated (Scheme 12). [108] Specifically,asmall-molecule synthesizer that assembles bifunctional MIDA-boronate building blocks through an automated deprotection, cross-coupling,and purification sequence was achieved. Most small-molecule targets lack ac ommon handle for covalent attachment to as olid support, precluding the use of solidphase synthesis as ag eneralized purification technique. Alternatively,i tw as discovered that MIDA-boronate-containing intermediates can be generally purified by taking advantage of au nique catch-and-release phenomenon on silica gel. Specifically,awide range of different MIDAboronates show no movement on silica gel with certain eluents (Et 2 O/MeOH) but are rapidly eluted with others (THF). This enabled the development of an ovel type of generalized and automated purification process that was coupled to automated iterative MIDA-boronate assembly.
Ab road range of small molecules from various classes have been assembled with this small-molecule synthesizer (Scheme 12). Examples range from pharmaceuticals to materials to natural products,with the latter class including some highly complex macrocyclic or polycyclic natural products or natural product motifs.I na ll of these cases,t he required functional groups,oxidation states,and stereochemistry were pre-installed into the corresponding building blocks,m ost of which were commercially available. [108] Hinting at the potential of such technology to bring the power of synthesis to nonspecialists,an ews reporter recently used this prototypical synthesizer to prepare as tereochemically complex natural product, [109] and agroup of high school students recently used it to make organic light emitting diodes. [110] There are many challenges that need to be overcome in order to maximize the generality of this platform and thereby gain on-demand automated access to large portions of targeted small-molecule chemical space.T hese include expanding the scope of cross-coupling to include awide range of Csp 3 and Xsp 3 coupling partners while maintaining excellent control of stereochemistry.A sm entioned above,i ncreased off-the-shelf access to building blocks that collectively cover large portions of small-molecule chemical space is also required. There is substantial reason for optimism that such challenges can be solved, and the impact of achieving generalized automated small-molecule synthesis platforms would be profound.
Automating Reaction Optimization, Molecular Design, and Functional Discovery
Apowerful series of advances in online reaction monitoring, machine self-optimization, and machine learning/artificial intelligence algorithms,a re rapidly emerging in parallel and have the potential to substantially enable the development of synthesizers that automate both customized and generalized synthesis routes. [111] End-to-end robot-mediated discovery has already been achieved for biological systems ( Figure 5 ). Robot-scientist "A dam" can autonomously generate hypotheses about genefunction relationships in the yeast Saccharomyces cerevisiae and experimentally test these hypotheses by using laboratory automation. [112] "Eve", an automated early-stage drug testing device,t ests subsets of compounds and identifies positive results using statistics and machine learning, and autonomously predicts new small molecule structures that are likely to return better results. [113] Closing the loop between automation and self-optimization in chemical small-molecule synthesis is also gaining momentum. In 2008, the Engineering and Physical Sciences ResearchC ouncil (EPSRC)s tarted funding networks to provide solutions for grand challenges in chemistry.A mong the funded networks is Dial-a-Molecule,which targets acontinuous-flow platform for synthetic chemistry with integrated analytics and automated feedback optimization to influence the reaction progress. [114] Buchwald and Jensen recently demonstrated self-optimization and automated feedback in combination with ac ontinuous-flow reactor to find optimal conditions for SuzukiMiyaura cross-coupling reaction improvement. They used as mart optimal design of experiments (DoE)-based algorithm to increase the turnover number and yield of the catalytic system considering both discrete variables (palladacycle and ligand) and continuous variables (temperature, time,a nd loading) simultaneously.A ll reaction data was examined by online HPLC-analysis,and 96 reactions were in general necessary to find optimal conditions.W ith this study they gained key mechanistic insights into the coupling reactions as well as optimal conditions for each reaction tested (Scheme 13). [115] Cronin and co-workers also created as elf-optimizing reactor system using real-time in-line NMR spectroscopy for data analysis.U tilizing 13 C, 19 F, and 2D NMR spectra of reaction mixtures under flow conditions,this technique allows avariety of kinetic and mechanistic studies.Self-optimization in flow reactors was achieved by employing in-line 1 HNMR. As model reactions,a ni mine-formation and electrophilic fluorination were chosen (Scheme 14). Current efforts include applying as imilar system for the discovery of new compounds. [116] Bourne,M uller,a nd co-workers alternatively employed acombination of HPLC as well as MS in positive atmospheric pressure chemical ionization mode for online data analysis. They were able to gather multistep kinetic information about an ucleophilic aromatic substitution (Scheme 15 A) [117] and showed self-optimization of different reactions with their systems (Scheme 15 B,C). [118] There is even emerging support for the notion of "artificial imagination" (Figure 6 ), which has the theoretical potential to enable the automated design of new molecular functions.F or example,l ast year, the Google AI AlphaGo won ag ame of Go against ap rofessional human player by utilizing human-like imagination. Thet eam used general machine learning techniques to create as ystem that learned on its own. It is proposed, that with enough training, processing, and search power such algorithms could outperform humans in many problem-solving tasks. [119] Hinting at such potential, Aspuru-Guzik and co-workers recently demonstrated the potential of machine learning to promote the discovery of next generation organic materials, [120] and there are exciting signs that such techniques can powerfully enable drug discovery. [121] It is exciting to consider the tremendous potential of creating ac losed loop that interfaces such technology with automated small molecule synthesis and functional characterization.
Conclusion and Future Outlook
Relative to the long history of toolmaking on the macroscopic scale,the history of rational small molecule synthesis is extremely brief.V iewed through this lens,t he macroscopic Industrial Revolution and its transformative impact on our current world is inspiring.M ajor advances in the automated synthesis of certain types of biomolecules have already had am ajor impact, suggesting that perhaps the molecular industrial revolution has already been active for decades in certain biological contexts.G iven the vast, and in many instances unique,u ntapped functional potential that small molecules possess,i ti se xciting to consider the tremendous societal impact that could be achieved by likewise broadly enabling innovation in this chemical space.
Substantial progress has recently been achieved in automating customized synthesis routes to specific small-molecule targets,and such technologies are already making asignificant industrial impact. Albeit more challenging,t here is also encouraging progress toward generalized small-molecule synthesizers.T his has been achieved using two different approaches:1)A utomating the classical customized approach to each target by creating highly versatile synthesis machines that can perform many different reactions and employ many different starting materials,a nd 2) developing more general building-block-based approaches for small-molecule synthesis that leverage inherent modularity and only require automating af ew chemical reactions.
Parallel advances in online reaction monitoring, selfoptimization, and machine learning/artificial intelligence stand to powerfully synergize with these evolving automated synthesis platforms.Itisinspiring to consider the prospect of generally closing the loop for design, synthesis,and testing at the molecular scale.A chieving this goal has the potential to transform automated synthesis into automated functional discovery.
Continued progress in all of these directions has the potential to shift the bottleneck in molecular innovation from synthesis to imagination (human or artificial!),a nd thereby help drive the new industrial revolution on the molecular scale. Angewandte Chemie
